QHSLab, Inc. Files 8-K: Regulation FD Disclosure & Exhibits
Ticker: USAQ · Form: 8-K · Filed: Oct 21, 2024 · CIK: 856984
Sentiment: neutral
Topics: disclosure, exhibits, regulation-fd
TL;DR
QHSLab filed an 8-K for Reg FD disclosure and exhibits. No major news yet.
AI Summary
On October 21, 2024, QHSLab, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific financial transactions or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates QHSLab, Inc. is making a required disclosure under Regulation FD and submitting exhibits, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not report any negative events or significant financial changes.
Key Players & Entities
- QHSLab, Inc. (company) — Registrant
- October 21, 2024 (date) — Date of report
- Regulation FD (regulation) — Disclosure item
- Financial Statements and Exhibits (document_type) — Filing item
- Nevada (state) — State of Incorporation
- West Palm Beach, FL (location) — Business and Mail Address
FAQ
What specific information is being disclosed under Regulation FD?
The provided excerpt does not detail the specific content of the Regulation FD disclosure, only that it is being filed.
What types of exhibits are included in this filing?
The excerpt states that 'Financial Statements and Exhibits' are included, but does not specify the nature of the exhibits.
Has QHSLab, Inc. undergone any recent name changes?
Yes, the filing indicates previous names including USA EQUITIES CORP. and AMERICAN BIOGENETIC SCIENCES INC, with name change dates in 2015 and 1994 respectively.
What is the business address of QHSLab, Inc.?
The business address is 901 Northpoint Parkway, Suite 302, West Palm Beach, FL 33407.
What is the SIC code for QHSLab, Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 614 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-10-21 09:00:09
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value USAQ N/A Item 7.01 Regu
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 21KB
- ex99-1_001.jpg (GRAPHIC) — 6KB
- 0001493152-24-041717.txt ( ) — 242KB
- usaq-20241021.xsd (EX-101.SCH) — 3KB
- usaq-20241021_lab.xml (EX-101.LAB) — 33KB
- usaq-20241021_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 21, 2024 QHSLab, Inc. /s/ Troy Grogan Name: Troy Grogan Title: CEO and Chairman